Etanercept suppresses arteritis in a murine model of kawasaki disease: A comparative study involving different biological agents

International Journal of Vascular Medicine

Volumn 2013, Issue , 2013, Pages

  Ohashi, Ryuji ^a   Fukazawa, Ryuji ^a   Watanabe, Makoto ^a   Tajima, Hanako ^a   Nagi Miura, Noriko ^b   Ohno, Naohito ^b   Tsuchiya, Shinichi ^a   Fukuda, Yuh ^a   Ogawa, Shunichi ^a   Itoh, Yasuhiko ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ETANERCEPT; IMMUNOGLOBULIN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 6; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTERITIS; ARTICLE; CANDIDA ALBICANS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFICACY; MALE; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PRIORITY JOURNAL;

EID: 84877280696     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2013/543141     Document Type: Article

References (43)

1. Kawasaki T., Kosaki F., Okawa S., Shigematsu I., Yanagawa H., A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974 54 3 271 276 2-s2.0-0016109145
2. Fukazawa R., Ikegam E., Watanabe M., Hajikano M., Kamisago M., Katsube Y., Yamauchi H., Ochi M., Ogawa S., Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence. Circulation Journal 2007 71 5 709 715 2-s2.0-34247606564 10.1253/circj.71.709 (Pubitemid 46683362)
3. Ogawa S., Fukazawa R., Ohkubo T., Zhang J., Takechi N., Kuramochi Y., Hino Y., Jimbo O., Katsube Y., Kamisago M., Genma Y., Yamamoto M., Silent myocardial ischemia in Kawasaki disease: evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation 1997 96 10 3384 3389 2-s2.0-0030827576 (Pubitemid 27513409)
4. Leung D. Y. M., Meissner H. C., Shulman S. T., Mason W. H., Gerber M. A., Glode M. P., Myones B. L., Wheeler J. G., Ruthazer R., Schlievert P. M., Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. Journal of Pediatrics 2002 140 6 742 746 2-s2.0-0036085255 10.1067/mpd.2002. 123664 (Pubitemid 34666695)
5. Furusho K., Kamiya T., Nakano H., High-dose intravenous gammaglobulin for Kawasaki disease. The Lancet 1984 2 8411 1055 1058 2-s2.0-0021702429 (Pubitemid 15211522)
6. Newburger J. W., Takahashi M., Burns J. C., The treatment of Kawasaki syndrome with intravenous gamma globulin. The New England Journal of Medicine 1986 315 6 341 347 2-s2.0-0022485186 (Pubitemid 16060087)
7. Newburger J. W., Takahashi M., Gerber M. A., Gewitz M. H., Tani L. Y., Burns J. C., Shulman S. T., Bolger A. F., Ferrieri P., Baltimore R. S., Wilson W. R., Baddour L. M., Levison M. E., Pallasch T. J., Falace D. A., Taubert K. A., Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004 114 6 1708 1733 2-s2.0-16244390429 10.1542/peds.2004-2182 (Pubitemid 41754943)
8. Wright D. A., Newburger J. W., Baker A., Sundel R. P., Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. Journal of Pediatrics 1996 128 1 146 149 2-s2.0-0030028803 10.1016/S0022- 3476(96)70447-X (Pubitemid 26028974)
9. Adachi S., Sakaguchi H., Kuwahara T., Uchida Y., Fukao T., Kondo N., High regression rate of coronary aneurysms developed in patients with immune Globulin-Resistant Kawasaki disease treated with steroid pulse therapy. Tohoku Journal of Experimental Medicine 2010 220 4 285 290 2-s2.0-77951230558 10.1620/tjem.220.285
10. Jibiki T., Kato I., Shiohama T., Abe K., Anzai S., Takeda N., Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease. Pediatrics International 2011 53 5 729 735
11. Raman V., Kim J., Sharkey A., Chatila T., Response of refractory Kawasaki disease to pulse steroid and cyclosporin a therapy. Pediatric Infectious Disease Journal 2001 20 6 635 637 2-s2.0-0034972003 10.1097/00006454-200106000- 00022 (Pubitemid 32567732)
12. Wallace C. A., French J. W., Kahn S. J., Sherry D. D., Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000 105 6, article E78 2-s2.0-17744411736
13. Mori M., Imagawa T., Katakura S., Miyamae T., Okuyama K. I., Ito S., Nakamura T., Kimura H., Yokota S., Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin. Modern Rheumatology 2004 14 1 43 47 2-s2.0-20444364206 10.1007/s10165-003-0264-3 (Pubitemid 40796159)
14. Kobayashi T., Saji T., Otani T., Takeuchi K., Nakamura T., Arakawa H., Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. The Lancet 2012 379 1613 1620
15. Nakamura Y., Yashiro M., Uehara R., Sadakane A., Tsuboi S., Aoyama Y., Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. Journal of Epidemiology 2012 22 3 216 221
16. Matsubara T., Ichiyama T., Furukawa S., Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clinical and Experimental Immunology 2005 141 3 381 387 2-s2.0-23044466605 10.1111/j.1365-2249.2005.02821.x (Pubitemid 41075860)
17. Gupta M., Noel G. J., Schaefer M., Friedman D., Bussel J., Johann-Liang R., Cytokine modulation with immune γ -globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. Journal of Clinical Immunology 2001 21 3 193 199 2-s2.0-0035026315 10.1023/A:1011039216251 (Pubitemid 32434306)
18. Kim D. S., Lee H. K., Noh G. W., Lee S. I., Lee K. Y., Increased serum Interleukin-10 level in Kawasaki disease. Yonsei Medical Journal 1996 37 2 125 130 2-s2.0-0030117515 (Pubitemid 126450976)
19. Furukawa S., Matsubara T., Umezawa Y., Okumara K., Yabuta K., Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. Journal of Pediatrics 1994 124 5 721 725 2-s2.0-0028240358 10.1016/S0022-3476(05)81361-7 (Pubitemid 24161460)
20. Kim D. S., Lee K. Y., Serum soluble E-selectin levels in kawasaki disease. Scandinavian Journal of Rheumatology 1994 23 5 283 286 2-s2.0-0028034267 (Pubitemid 24334036)
21. Hui-Yuen J. S., Duong T. T., Yeung R. S. M., TNF- α is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. Journal of Immunology 2006 176 10 6294 6301 2-s2.0-33646482709
22. Choueiter N. F., Olson A. K., Shen D. D., Portman M. A., Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease. Journal of Pediatrics 2010 157 6 960.e1 966.e1 2-s2.0-78449280363 10.1016/j.jpeds.2010.06.014
23. Son M. B., Gauvreau K., Burns J. C., Corinaldesi E., Tremoulet A. H., Watson V. E., Baker A., Fulton D. R., Sundel R. P., Newburger J. W., Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. Journal of Pediatrics 2011 158 4 644.e1 649.e1 2-s2.0-79952573721 10.1016/j.jpeds.2010.10.012
24. Nagi-Miura N., Harada T., Shinohara H., Kurihara K., Adachi Y., Ishida-Okawara A., Oharaseki T., Takahashi K., Naoe S., Suzuki K., Ohno N., Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction. Atherosclerosis 2006 186 2 310 320 2-s2.0-33646386397 10.1016/j.atherosclerosis.2005.08.014
25. Hirata N., Ishibashi K. I., Usui T., Yoshioka J., Hata S., Adachi Y., A model of left ventricular dysfunction complicated by CAWS arteritis in DBA/2 mice. International Journal of Vascular Medicine 2012 2012 9 570297 10.1155/2012/570297
26. Uchiyama M., Ohno N., Miura N. N., Adachi Y., Aizawa M. W., Tamura H., Tanaka S., Yadomae T., Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. FEMS Immunology and Medical Microbiology 1999 24 4 411 420 2-s2.0-0033005446 10.1016/S0928-8244(99)00058-9 (Pubitemid 29313320)
27. Takahashi K., Oharaseki T., Yokouchi Y., Miura N. N., Ohno N., Okawara A. I., Murata H., Naoe S., Suzuki K., Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease. Modern Rheumatology 2010 20 2 160 167 2-s2.0-77954760180 10.1007/s10165-009-0250-5
28. Lang B. A., Silverman E. D., Laxer R. M., Lau A. S., Spontaneous tumor necrosis factor production in Kawasaki disease. Journal of Pediatrics 1989 115 6 939 943 2-s2.0-0024408746 10.1016/S0022-3476(89)80746-2 (Pubitemid 20007081)
29. Eberhard B. A., Andersson U., Laxer R. M., Rose V., Silverman E. D., Evaluation of the cytokine response in Kawasaki disease. Pediatric Infectious Disease Journal 1995 14 3 199 203 2-s2.0-0028913671
30. Jibiki T., Terai M., Kohno Y., High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease. European Journal of Pediatrics 2004 163 12 749 750 2-s2.0-11244327850 10.1007/s00431-004-1539-1 (Pubitemid 40064386)
31. Oharaseki T., Kameoka Y., Kura F., Persad A. S., Suzuki K., Naoe S., Susceptibility loci to coronary arteritis in animal model of Kawasaki disease induced with Candida albicans -derived substances. Microbiology and Immunology 2005 49 2 181 189 2-s2.0-14944379035 (Pubitemid 40364138)
32. Takahashi K., Oharaseki T., Nagao T., Yokouchi Y., Yamada H., Nagi-Miura N., Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease. Pediatric Rheumatology Online Journal 2011 9 1 30
33. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P. H., Wagner H., T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. Journal of Experimental Medicine 1992 175 1 91 98 2-s2.0-0026596020 10.1084/jem.175.1.91
34. Pober J. S., Endothelial activation: intracellular signaling pathways. Arthritis Research & Therapy 2002 4, supplement 3 S109 S116
35. Selmaj K., Walczak A., Mycko M., Berkowicz T., Kohno T., Raine C. S., Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4. European Journal of Immunology 1998 28 6 2035 2044 (Pubitemid 28271720)
36. O'Dell J. R., Anticytokine therapy-a new era in the treatment of rheumatoid arthritis? The New England Journal of Medicine 1999 340 4 310 312 2-s2.0-0033611515 10.1056/NEJM199901283400411 (Pubitemid 29063276)
37. Takahashi K., Oharaseki T., Naoe S., Wakayama M., Yokouchi Y., Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatrics International 2005 47 3 305 310 2-s2.0-20444503366 10.1111/j.1442-200x.2005.02049.x (Pubitemid 40827508)
38. Takahashi K., Oharaseki T., Wakayama M., Yokouchi Y., Naoe S., Murata H., Histopathological features of murine systemic vasculitis caused by Candida albicans extract-an animal model of Kawasaki Disease. Inflammation Research 2004 53 2 72 77 2-s2.0-1242306733 10.1007/s00011-003-1225-1 (Pubitemid 38223372)
39. Hirata N., Ishibashi K. I., Ohta S., Hata S., Shinohara H., Kitamura M., Miura N., Ohno N., Histopathological examination and analysis of mortality in DBA/2 mouse vasculitis induced with CAWS, a water-soluble extracellular polysaccharide fraction obtained from Candida albicans. Yakugaku Zasshi 2006 126 8 643 650 2-s2.0-33746796741 10.1248/yakushi.126.643 (Pubitemid 44180771)
40. Kato H., Koike S., Yokoyama T., Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979 63 2 175 179 2-s2.0-0018371902 (Pubitemid 9083134)
41. Wooditch A. C., Aronoff S. C., Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics 2005 116 4 989 995 2-s2.0-33644665487 10.1542/peds.2005-0504 (Pubitemid 44542830)
42. Inoue Y., Okada Y., Shinohara M., Kobayashi T., Kobayashi T., Tomomasa T., Takeuchi K., Morikawa A., A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. Journal of Pediatrics 2006 149 3 336.e1 341.e1 2-s2.0-33747875063 10.1016/j.jpeds.2006.05.025 (Pubitemid 44308435)
43. Ogata S., Ogihara Y., Honda T., Kon S., Akiyama K., Ishii M., Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Pediatrics 2012 129 1 e17 e23